MedPath

成都地奥制药集团有限公司

Ownership
-
Established
1988-08-25
Employees
-
Market Cap
-
Website
www.diao.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

15

NMPA:15

Drug Approvals

Sildenafil Citrate Tablets

Product Name
枸橼酸西地那非片
Approval Number
国药准字H20247308
Approval Date
Dec 9, 2024
NMPA

Thymalfasin for Injection

Product Name
注射用胸腺法新
Approval Number
国药准字H20249159
Approval Date
Oct 22, 2024
NMPA

银黄含片

Approval Number
国药准字Z10940042
Approval Date
May 9, 2024
NMPA

地奥心血康片

Approval Number
国药准字Z10950023
Approval Date
Mar 22, 2024
NMPA

地奥心血康胶囊

Approval Number
国药准字Z10910051
Approval Date
Feb 6, 2024
NMPA

Amlodipine Besylate and Benazepril Hydrochloride Tablets(Ⅱ)

Product Name
氨氯地平贝那普利片(Ⅱ)
Approval Number
国药准字H20090309
Approval Date
May 30, 2023
NMPA

Sildenafil Citrate Tablets

Product Name
枸橼酸西地那非片
Approval Number
国药准字H20174092
Approval Date
Sep 20, 2022
NMPA

Glucosamine Sulfate and Potassium Chloride Capsules

Product Name
端正
Approval Number
国药准字H20051272
Approval Date
Apr 13, 2021
NMPA

地奥心血康软胶囊

Approval Number
国药准字Z20050616
Approval Date
Oct 29, 2020
NMPA

Benazepril Hydrochloride Tablets

Product Name
盐酸贝那普利片
Approval Number
国药准字H20053390
Approval Date
Nov 15, 2019
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.